Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention Intravacc’s recent research, featured in the peer-reviewed journal ‘Current Opinion in Immunology’ Volume 84 (2023), explores the potential of OMV-based vaccines in mucosal immunization. OMVs, derived from Gram-negative bacteria, demonstrate promise as versatile vaccine candidates. Administered intranasally, they exhibit the capacity to carry diverse…
